New Pediatric Tumor Identifications Could Help Predict Chemo Response

A new UC San Francisco study sheds light on the diversity within the most common type of pediatric liver tumor and suggests a way forward for more precise chemotherapy treatment. The study, publishing in Nature Communications on August 25, used single-cell transcriptomic techniques to analyze

Trial Library Emerges Out of Stealth with $5 Million in Seed Funding

Trial Library, Inc., an oncology clinical trials company, today announced it has come out of stealth mode and received its first funding to address the need for equity in patient recruitment to oncology clinical trials. The $5 million seed round was led by Deena Shakir, Partner at Lux Capital, with

Pre-eminent Scientist, Collaborator, Mentor: Q&A with Nola Hylton, PhD

Abortion Ban May Increase Risk of Death for Pregnant Women with Cancer

Abortion Ban May Increase the Risk of Death for Pregnant Women with Cancer

Watch the video below from ABC7 News.

Eleven Cancer Research Projects Funded in Spring 2022 RAP Cycle

Eleven investigators and teams were awarded grants in support of cancer research projects in the spring 2022 cycle of the UCSF Resource Allocation Program (RAP). Funded by various agencies across UCSF, the awards span a range of topics from cancer screening to image-guided drug delivery to

Hearing Loss and Tinnitus Are Common In Cancer Survivors

While children receiving chemotherapy routinely undergo hearing tests, adults don’t, and a new study by UC San Francisco reports for the first time that significant hearing issues often occur among adult survivors of the most common forms of cancer. The researchers found that more than half the